Individually Tailored Treatment With Epirubicin and Paclitaxel With or Without Capecitabine as First-Line Chemotherapy in Metastatic Breast Cancer: A Randomized Multicenter Trial
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-011-1880-9
Full Text
Open PDFAbstract
Available in full text
Date
November 18, 2011
Authors
Publisher
Springer Science and Business Media LLC